Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Haese

Showing results (111-120 of 214) with videos related to

Pageof 22
Sort By:
World Journal of Urology|December 2, 2024
Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: a matched-pair analysisFrancesca Ambrosini, Johanna Hagemann, Randi Pose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancerThorsten Schlomm, Patrick Kirstein, Liv Iwers, et al.
World Journal of Urology|March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patientsJonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
World Journal of Urology|October 14, 2018
Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United StatesFelix Preisser, Sebastiano Nazzani, Elio Mazzone, et al.
British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.
World Journal of Urology|July 2, 2011
Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinionBertrand Tombal, Filip Ameye, Alexandre de la Taille, et al.
BMC Cancer|August 18, 2016
Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patientsMaria-Christina Tsourlakis, Annegret Stender, Alexander Quaas, et al.
BJU International|September 24, 2013
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European populationAndreas Becker, Pierre Tennstedt, Jens Hansen, et al.
European Urology|May 18, 2012
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patientsThorsten Schlomm, Pierre Tennstedt, Caroline Huxhold, et al.
The Prostate|September 3, 2010
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancerSarah Minner, Corinna Wittmer, Markus Graefen, et al.
Pageof 22

Showing results (111-120 of 214) with videos related to

Sort By:
Pageof 22
World Journal of Urology|December 2, 2024
Surgical and oncological outcomes of salvage radical prostatectomy after focal therapies: a matched-pair analysisFrancesca Ambrosini, Johanna Hagemann, Randi Pose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancerThorsten Schlomm, Patrick Kirstein, Liv Iwers, et al.
World Journal of Urology|March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patientsJonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
World Journal of Urology|October 14, 2018
Regional differences in total hospital charges between open and robotically assisted radical prostatectomy in the United StatesFelix Preisser, Sebastiano Nazzani, Elio Mazzone, et al.
British Journal of Cancer|May 30, 2020
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomyAlexander Haese, Amy L Tin, Sigrid V Carlsson, et al.
World Journal of Urology|July 2, 2011
Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinionBertrand Tombal, Filip Ameye, Alexandre de la Taille, et al.
BMC Cancer|August 18, 2016
Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patientsMaria-Christina Tsourlakis, Annegret Stender, Alexander Quaas, et al.
BJU International|September 24, 2013
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European populationAndreas Becker, Pierre Tennstedt, Jens Hansen, et al.
European Urology|May 18, 2012
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patientsThorsten Schlomm, Pierre Tennstedt, Caroline Huxhold, et al.
The Prostate|September 3, 2010
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancerSarah Minner, Corinna Wittmer, Markus Graefen, et al.
Pageof 22